Physician
Pathology
Dr. Kanishka Sircar, MD
|
|
Give Review
Dr. Kanishka Sircar works in the field of Pathology. He received awards:"Examiner, Anatomic Pathology". Dr. Kanishka Sircar is a published doctor. He has 52 publications published. The most current publication "Interstitial cells of Cajal: pacemaker cells?" Kanishka Sircar accepts Medicare.
Publications
- Preexisting adrenal masses in patients with adrenocortical carcinoma: clinical and radiological factors contributing to delayed diagnosis.
- Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
- Hepatocyte growth factor/cMET pathway activation enhances cancer hallmarks in adrenocortical carcinoma.
- Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
- Kidney cancer, version 3.2015.
- Isolated Renal Mucormycosis in a Transplantation Recipient.
- Clinical and Radiological Features of Pheochromocytoma/Ganglioneuroma Composite Tumos: A Case Series with Comparative Analysis.
- Diagnostic and prognostic role of immunohistochemical expression of napsin-a aspartic peptidase in clear cell and papillary renal cell carcinoma: a study including 233...
- Kidney cancer, version 2.2014.
- Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study.
- Enhancer of Zeste Homolog 2 Expression Is Associated With Metastasis and Adverse Clinical Outcome in Clear Cell Renal Cell Carcinoma: A Comparative Study and Review of...
- Adrenocortical carcinoma: Clinical outcomes and prognosis of 330 patients at a tertiary care center.
- The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.
- Contemporary approach to diagnosis and classification of renal cell carcinoma with mixed histologic features.
- Plasmacytoid Urothelial Carcinomas - A Chemo-sensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis.
- Banking of fresh-frozen prostate tissue using the alternate mirror image protocol: methods, validation, and impact on the pathological prognostic parameters in radical...
- Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
- Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
- Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revisio...
- 18FFluorodeoxyglucose Positron Emission Tomography-Guided Therapy in Metastatic Adrenocortical Carcinoma: An Illustrative Case.
- Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists(☆).
- Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer.
- Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer.
- Integrative molecular profiling reveals asparagine synthetase is a target in castration-resistant prostate cancer.
- Modeling Lethal Prostate Cancer Variant with Small Cell Carcinoma Features.
- PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications.
- Systemic therapy for sarcomatoid renal cell carcinoma.
- The mammalian target of rapamycin pathway is widely activated without PTEN deletion in renal cell carcinoma metastases.
- ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.
- Prioritizing genes associated with prostate cancer development.
- Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
- Plasmacytoid urothelial carcinoma of the bladder: a case report.
- Renal cell carcinoma with inferior vena caval extention: impact of tumour extent on surgical outcome.
- PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer.
- Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer.
- Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.
- Co-assessment of cytoplasmic and nuclear androgen receptor location in prostate specimens: potential implications for prostate cancer development and prognosis.
- NOXA and PUMA expression add to clinical markers in predicting biochemical recurrence of prostate cancer patients in a survival tree model.
- Sonographic diagnosis of a ruptured intratesticular pseudoaneurysm secondary to orchitis.
- BCG for upper-tract transitional-cell carcinoma: is it safe in patients with renal compromise?
- Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation.
- Isolation of human prostatic epithelial plasma membranes for proteomics using mirror image tissue banking of radical prostatectomy specimens.
- Somatic mosaicism and cancer: a micro-genetic examination into the role of the androgen receptor gene in prostate cancer.
- Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy.
- Feasibility of simultaneous testicular microdissection for sperm retrieval and ipsilateral testicular tumor resection in azoospermic men.
- Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
- Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results.
- Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor.
- Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal.
- Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors.
- Interstitial cells of Cajal: pacemaker cells?
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Awards
- Examiner, Anatomic Pathology
Education
-
Memorial Sloan-Kettering Cancer Center -
McGill University Faculty of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396904926 |
| Last Name Of The Provider | SIRCAR |
| First Name Of The Provider | KANISHKA |
| View All |
Similar Doctors
|
|
Dr. Louis M. Buja, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Lawrence J. Hartley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bojana Djordjevic, MD |
|
|
Dr. Peggy B. Delahoussaye, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anna E. Sienko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rita F. Tibbs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jing Liu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Baljit K. Nanda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sa A. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Regina R. Verani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joye M. Carter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sagar A. Dhamne, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Savitri Krishnamurthy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Sarah V. Kelly |